Company intelligence / Profile preview

Finlumen

Kilkenny, Ireland

Ownership: Private
Development stage: Other

Overview

FinLumen was a medical device company focused on developing innovative solutions for the treatment of chronic total occlusions (CTO) in the peripheral vasculature. The company's primary product was a crossing catheter designed to facilitate the passage of guidewires through completely blocked arteries, a common challenge in treating peripheral artery disease. By providing a more effective way to navigate complex vascular blockages, FinLumen aimed to improve procedural success rates and patient outcomes. The company was acquired by Teleflex Incorporated in 2011 to enhance their interventional access portfolio.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Finlumen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Finlumen.

Explore the full profile